The FDA unveiled a new set of regulations calling for supplement companies to offer "competent and reliable scientific evidence" for health claims made on packages. The move was spurred by recent health concerns surrounding two popular supplements, ephedra and androstenedione, which have already been removed from store shelves.

Related Summaries